Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial peptide/organic cation transporters, primarily represented by the Proton-dependent Oligopeptide Transporter (POT) family (also known as the PTR family), are integral membrane proteins that facilitate the uptake of di- and tri-peptides from the extracellular environment into the bacterial cytoplasm [2]. These transporters are members of the Major Facilitator Superfamily (MFS) and function as symporters, utilizing the inward-directed proton electrochemical gradient (proton motive force) to drive substrate transport [2, 10]. Beyond their physiological role in nutrient acquisition and nitrogen metabolism, these transporters are of significant pharmacological interest because they can recognize and transport a wide variety of peptidomimetic drugs, including beta-lactam antibiotics like cephalosporins (e.g., cephalexin, cefadroxil) and various peptide-conjugated prodrugs [2, 11]. By hijacking these nutrient uptake pathways, these drugs can achieve high intracellular concentrations, which is essential for their antimicrobial efficacy [2]. The study of bacterial POTs, such as DtpA from Escherichia coli, has provided critical structural and functional insights into the mechanism of peptide transport, serving as a model for understanding human homologs like PEPT1 and PEPT2 [6, 10]. Consequently, these transporters are considered important targets for improving drug delivery and overcoming certain types of bacterial resistance [2, 11].
Facilitated uptake of peptidomimetic drugs via proton-coupled symport
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proton-dependent oligopeptide transporter (POT) (POT).